Who are Verastem, Inc.'s main suppliers?

Verastem, Inc. (VSTM) key suppliers include: Sanofi. View the full supplier network at chainsifter.com/chain/VSTM.

Who are Verastem, Inc.'s major customers?

Verastem, Inc. (VSTM) key customers include: PANCREATIC-CANCER-NETWORK, Sanofi, Sanofi. View the full customer network at chainsifter.com/chain/VSTM.

What sector is Verastem, Inc. in?

Verastem, Inc. (VSTM) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Verastem, Inc. (VSTM): 7 Verified Supply Chain Relationships

1Suppliers

3Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Verastem, Inc. (VSTM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships

3Distinct source URLs

5High confidence

0.835Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Verastem, Inc. Suppliers

Ticker	Name	Confidence	Evidence
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from VSTM graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from VSTM graph: Reciprocal relationship from SNYN…

Verastem, Inc. Customers

Ticker	Name	Confidence	Evidence
PANCREATIC-CANCER-NETWORK	PANCREATIC-CANCER-NETWORK	92%	For the three months ended March 31, 2026, there were two customers who each individually accounted for greater than 10% of the Company’s total revenues. These two customers accounted for revenues of…
SNYNF	Sanofi	72%	cell lymphoma and a payment of $ million upon receipt of the first regulatory approval for the commercial sale of COPIKTRA in the European Union for the treatment of peripheral T-cell lymphoma, (ii) …
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from VSTM graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from VSTM graph: Reciprocal relationship from SNYN…

Verastem, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
VSTM-DEBT-13455	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
VSTM-DEBT	Debt stack $25.1M	90%	Market cache reports total debt of $25.1M.
VSTM-DEBT-13454	Warrants outstanding: 33792000	90%	xbrl warrant detail from xbrl 2025-12-31.

Verastem, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Verastem, Inc..

Verastem, Inc. Ownership

Holder	Name	Confidence	Evidence
VSTM-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 157 tracked holders.

Verastem, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
ADAG	Adagene Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
GRDX	GridAI Technologies Corp.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
CALC	CalciMedica, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
DBVTF	DBV TECHNOLOGIES	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
EDIT	Editas Medicine, Inc.	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
ATOS	Atossa Therapeutics, Inc.	100.00	2
BMRN	BioMarin Pharmaceutical Inc.	100.00	2

Verastem, Inc. Supply Chain